XSNX Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume1.00
Average Volume (3M)19.36K
Market Cap
$6.17K
Enterprise Value$2.18M
Total Cash (Recent Filing)$794.00
Total Debt (Recent Filing)$2.09M
Price to Earnings (P/E)―
Beta26.10
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding61,652,386
10 Day Avg. Volume19,357
30 Day Avg. Volume19,357
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.27
Price to Sales (P/S)0.00
P/FCF Ratio-3.32
Enterprise Value/Market Cap354.36
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-4.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NovAccess Global News
XSNX FAQ
What was NovAccess Global’s price range in the past 12 months?
NovAccess Global lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is NovAccess Global’s market cap?
NovAccess Global’s market cap is $6.17K.
When is NovAccess Global’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were NovAccess Global’s earnings last quarter?
Currently, no data Available
Is NovAccess Global overvalued?
According to Wall Street analysts NovAccess Global’s price is currently Overvalued.
Does NovAccess Global pay dividends?
NovAccess Global does not currently pay dividends.
What is NovAccess Global’s EPS estimate?
NovAccess Global’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NovAccess Global have?
NovAccess Global has 61,652,386 shares outstanding.
What happened to NovAccess Global’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of NovAccess Global?
Currently, no hedge funds are holding shares in XSNX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NovAccess Global
Operating as a biopharmaceutical firm, NovAccess Global Inc. focuses on developing innovative immunotherapies to treat individuals with brain tumors across the United States. Their primary expertise is in pioneering research that leverages a patient's own immune system to target and eliminate cancerous cells. The company, founded in 1997, has its headquarters situated in Chesterland, Ohio.
Scinai Immunotherapeutics
―
Artelo Biosciences
―
NewcelX
―
Dermata Therapeutics
―
Virax Biolabs Group Ltd. Class A
―